MedPath

Pulmonary Arterial Hypertension in Systemic Sclerosis

Conditions
Systemic Sclerosis
Pulmonary Arterial Hypertension
Registration Number
NCT00617487
Lead Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Brief Summary

The purpose of this study is to evaluate the role of stress echocardiography, compared to standard echocardiography in the early identification of pulmonary arterial hypertension in systemic sclerosis. To evaluate the role of BNP in this setting.To analyze data recorded with respect to the parameters commonly used for SSc evaluation (eg thorax HRCT, pulmonary function tests + DLCO, nailfold capillaroscopy, etc); these parameters are available starting for 1999.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients with systemic sclerosis according to LeRoy criteria
Exclusion Criteria
  • Pregnancy
  • Significant valvular disease
  • Low left ventricular function upon echocardiography (ejection fraction<55%)
  • History of atrial fibrillation, myocardial infarction, pulmonary thromboembolisms, neoplasia or severe hepatic disease.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

IRCCS Foundation Policlinico S. Matteo

🇮🇹

Pavia, PV, Italy

IRCCS Policlinico S. Matteo

🇮🇹

Pavia, PV, Italy

© Copyright 2025. All Rights Reserved by MedPath